Peter Cherry

Peter Cherry has a diverse work experience in the field of computational chemistry and software development. Peter started as an Undergraduate Research Scholar at the University of Warwick in 2009, where they focused on a research project related to neutrino detection. Peter then pursued a Postgraduate Research position at the University of Southampton from 2011 to 2013, applying computational models for fuel cell catalyst design.

After that, they worked as a Marie Curie Research Fellow at the Slovak Academy of Sciences from 2013 to 2016, during which they developed the relativistic spectroscopy code ReSpect-mDKS and administered the Linux cluster of the Theoretical Department. Peter had several secondments during this time at different research institutions in Europe.

Peter continued their career as a Postdoctoral Fellow at Northwestern University from 2017 to 2018, where they developed software for easy implementation of molecular properties in a relativistic, post-Hartree-Fock framework.

From 2018 to 2019, they interned at the Innovation and New Ventures Office of Northwestern University, gaining experience in technology transfer.

Their most recent role was as a Research Fellow at the Slovak Academy of Sciences starting in 2019, where they focused on developing a software library of numerical solvers optimized for eigenproblems relevant to time-dependent density functional theory.

In 2020, Peter Cherry joined Cresset software and discovery as a Computational Chemistry Developer. The role's details were not specified further.

Peter Cherry's education history is as follows:

From 2006 to 2010, Peter attended the University of Warwick and obtained a Bachelor's degree in Physics (MPhys).

In 2010, they enrolled at King's College London and completed a Master's degree (MA) in Philosophy in 2011.

Following this, from 2011 to 2013, they attended the University of Southampton, where they pursued a Master of Philosophy (MPhil) degree in Computational Science.

From 2013 to 2016, Peter pursued a Doctor of Philosophy (PhD) degree in Physics at Comenius University.

Currently, Peter is pursuing further education at UCL, where they started in 2021 and is expected to complete a Master of Science (MSc) degree in Pharmaceutics and Drug Design by 2025.